for the next several days, with relatives keeping a constant vigil, robert held the hand of his wife, who was hooked up to an iv and lethargic from pain medication..

the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�..

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people..